Will UnitedHealth (UNH) rebound in 2026 or is this healthcare giant stuck in a death spiral?

**UnitedHealth (UNH) is likely to rebound in 2026**, and here's why:

1. **Analyst Optimism**: J.P. Morgan analyst Lisa Gill has assigned an Overweight rating to UnitedHealth with a $418 price target, suggesting a potential rebound of 48% in the coming 12 months. This indicates confidence in the company's future performance.
2. **Supportive Forecasts**: The trend forecast for UnitedHealth shows a 71% probability of trend continuation, with the current bearish trend expected to persist for 21 days. However, the forecast also suggests a potential shift away from bearishness, which could pave the way for a rebound.

3. **Price Target Insights**: The forecast price for UnitedHealth for the end of 2025 ranges from $221.99 to $260.05, with a mean forecast price of $247.37. This indicates a potential for the stock to move higher in the near term, which could be the beginning of a rebound.

4. **Market Sentiment**: Despite a recent drop in the stock price due to lowered earnings targets, the overall sentiment remains positive, with expectations of a rebound driven by strong fundamentals and strategic positioning in the healthcare sector.

In conclusion, UnitedHealth is poised for a potential rebound in 2026, driven by analyst optimism, supportive forecasts, and favorable market sentiment.